Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium citrate is the calcium salt of citric acid and is commonly used as a dietary supplement to prevent or treat low blood calcium levels. It is also used as a food additive and preservative. As a supplement or medication taken orally (by mouth), it increases plasma calcium levels by providing bioavailable elemental calcium. This action reduces secretion of parathyroid hormone (PTH) via stimulation of the G-protein coupled calcium-sensing receptor on parathyroid cells. Lower PTH decreases bone resorption and increases bone mineral density by promoting deposition of more calcium into bone tissue[3][9]. Calcium plays essential roles in nerve conduction, muscle contraction (including cardiac muscle function), blood clotting processes and maintaining strong bones[7]. The drug may be indicated for conditions such as osteoporosis prevention/treatment and other states associated with hypocalcemia including osteomalacia/rickets or hypoparathyroidism[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium citrate.